2020
DOI: 10.1200/go.20.00220
|View full text |Cite
|
Sign up to set email alerts
|

Telemedicine During the COVID-19 Pandemic: Impact on Care for Rare Cancers

Abstract: PURPOSE Many patients with cancer, often those with rare cancers such as sarcomas, travel long distances to access expert care. The COVID-19 pandemic necessitated widespread changes in delivery of cancer care, including rapid adoption of telemedicine-based care. We aimed to evaluate the impact of telemedicine on patients, clinicians, and care delivery at the Royal Marsden Hospital (RMH) Sarcoma Unit during the pandemic. METHOD… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

6
135
0
3

Year Published

2020
2020
2022
2022

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 104 publications
(144 citation statements)
references
References 9 publications
6
135
0
3
Order By: Relevance
“…(2020) India QI Audit Rheumatology Mar. 12–20, 2020 100 completed satisfaction survey Median age 54, 87% females Survey LOE VI Smrke et al. (2020) UK Descriptive Retrospective case series Rare Cancer Mar.…”
Section: Resultsmentioning
confidence: 99%
“…(2020) India QI Audit Rheumatology Mar. 12–20, 2020 100 completed satisfaction survey Median age 54, 87% females Survey LOE VI Smrke et al. (2020) UK Descriptive Retrospective case series Rare Cancer Mar.…”
Section: Resultsmentioning
confidence: 99%
“…While tele-oncology cannot substitute for some in-person visits, [ 21 ], clinicians and patients to date have had some positive experiences using telehealth services, including saving personal protective equipment (PPE) and reducing the need for hospital services [ 22 ]. Other evidence indicates that telehealth has not increased physicians’ workload and that both cancer patients and providers have expressed satisfaction with transitions to telehealth for certain services [ 23 ]. Recent surveys in various countries suggests that, while many patients still prefer in-person visits for some aspects of care, telehealth platforms offer a reasonable and satisfactory alternative for other cancer care services [ 11 , 24 , 25 ].…”
Section: Resultsmentioning
confidence: 99%
“…Rapid implementation of telemedicine during the COVID-19 pandemic has given us the opportunity to evaluate the acceptability of remote monitoring, showing that the majority of patients would prefer the incorporation of telemedicine in follow-up. Given the increasing pressures on global healthcare systems, including the National Health Service (NHS) in the UK, telemedicine may be an effective way to manage selected patients [27]. Preference for face to face appointments was associated with lower resilient coping and was more common in patients who did not know their treatment intent.…”
Section: Discussionmentioning
confidence: 99%
“…Questions developed for this survey included socio-demographic items, sarcoma management items, worry about COVID-19, psychosocial impact of the COVID-19 pandemic, and care experiences during the pandemic. Further details and preliminary results of the telemedicine section have been published elsewhere [27].…”
Section: Methodsmentioning
confidence: 99%